New patient derived lymphoma xenograft (PDX) panel for drug development, immuno-oncology and translational research. (October 2022) - Brzezicha, B.; Becker, M.; Stecklum, M.; Conrad, T.; Janz, M.; Bittner, A.; Schmitt, C.A.; Hoffmann, J.